Functional chimeras of the Rous sarcoma virus and human immunodeficiency virus gag proteins
about
Nucleocapsid and matrix protein contributions to selective human immunodeficiency virus type 1 genomic RNA packaging.RNA dimerization defect in a Rous sarcoma virus matrix mutant.An assembly domain of the Rous sarcoma virus Gag protein required late in buddingIdentification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipidsDifferential membrane binding of the human immunodeficiency virus type 1 matrix proteinFine mapping and characterization of the Rous sarcoma virus Pr76gag late assembly domainViral DNA synthesis defects in assembly-competent Rous sarcoma virus CA mutants.Association of human immunodeficiency virus type 1 gag with membrane does not require highly basic sequences in the nucleocapsid: use of a novel Gag multimerization assayInteraction of the human immunodeficiency virus type 1 nucleocapsid with actin.A proline-rich motif within the matrix protein of vesicular stomatitis virus and rabies virus interacts with WW domains of cellular proteins: implications for viral buddingLate domain function identified in the vesicular stomatitis virus M protein by use of rhabdovirus-retrovirus chimerasConditions for copackaging rous sarcoma virus and murine leukemia virus Gag proteins during retroviral budding.In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain.Identification of retroviral late domains as determinants of particle size.Biochemical characterization of rous sarcoma virus MA protein interaction with membranes.Genetic determinants of Rous sarcoma virus particle size.Analysis of the assembly function of the human immunodeficiency virus type 1 gag protein nucleocapsid domain.Type D retrovirus capsid assembly and release are active events requiring ATP.Particle size determinants in the human immunodeficiency virus type 1 Gag proteinAnalysis of minimal human immunodeficiency virus type 1 gag coding sequences capable of virus-like particle assembly and release.Pseudotype formation of Moloney murine leukemia virus with Sendai virus glycoprotein F.Importance of basic residues in the nucleocapsid sequence for retrovirus Gag assembly and complementation rescueRelationship between human immunodeficiency virus type 1 Gag multimerization and membrane binding.Basic residues in human immunodeficiency virus type 1 nucleocapsid promote virion assembly via interaction with RNA.Rescue of multiple viral functions by a second-site suppressor of a human immunodeficiency virus type 1 nucleocapsid mutation.Human immunodeficiency virus type 1 virion density is not determined by nucleocapsid basic residuesMapping and characterization of the N-terminal I domain of human immunodeficiency virus type 1 Pr55(Gag).Proline residues in human immunodeficiency virus type 1 p6(Gag) exert a cell type-dependent effect on viral replication and virion incorporation of Pol proteins.Translation elongation factor 1-alpha interacts specifically with the human immunodeficiency virus type 1 Gag polyproteinFormation of virus assembly intermediate complexes in the cytoplasm by wild-type and assembly-defective mutant human immunodeficiency virus type 1 and their association with membranes.The gag domains required for avian retroviral RNA encapsidation determined by using two independent assays.Human immunodeficiency virus type 1 Gag polyprotein multimerization requires the nucleocapsid domain and RNA and is promoted by the capsid-dimer interface and the basic region of matrix protein.Repositioning basic residues in the M domain of the Rous sarcoma virus gag proteinInsertion of capsid proteins from nonenveloped viruses into the retroviral budding pathway.Membrane targeting properties of a herpesvirus tegument protein-retrovirus Gag chimera.Activation of the Mason-Pfizer monkey virus protease within immature capsids in vitroVirus maturation by budding.Redundant roles for nucleocapsid and matrix RNA-binding sequences in human immunodeficiency virus type 1 assembly.p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing proteaseNucleocapsid protein effects on the specificity of retrovirus RNA encapsidation.
P2860
Q24523051-2C524103-7B48-4972-BF28-3A62F7420C6AQ24524289-EE58762E-9F27-43F1-99D3-EC79E352AA5BQ24645654-A7B2A48F-DB75-4583-A941-1CC689F34E65Q24646680-B56C425A-CB2B-42BD-9320-319075AAA0DEQ24679629-776DD306-7347-4229-B97C-1E1CEA6A2FF8Q30176873-40A612CD-8F55-4572-A48D-7460E46836A3Q30327614-5F2EA65C-4343-4458-A52B-9B476B241AEFQ30447057-EC72D343-BA41-4CF9-B4E2-8AD00745E5E8Q33643700-D09E5D68-ADAE-4DA9-9828-7ECF9C997ABEQ33643776-A228A10C-E6AD-4E01-AF8B-104CCB55841DQ33645178-E3B2FC53-3A5D-4E24-8C58-60416FBECA60Q33653116-D0653DE6-13A5-4800-978A-7DA0735E3EC8Q33653475-648ADD7D-3C9F-49E2-9DE0-44064CE6B177Q33653548-4057BC7A-ACEE-4A70-A473-3421AF20D8B3Q33780632-9BC46203-8169-459D-923D-923395E6B6ADQ33782075-A90F5A41-9DB0-4FBD-872B-4E5552E8DBCAQ33782263-F99F4226-7468-40A7-9CF2-7869020C212AQ33783128-2661B3D1-D519-4DA9-BEA0-95F82E768223Q33783955-FD128F6B-293E-48B8-97C1-56F40B419E2CQ33784754-883A7F77-8F7D-4D58-9E97-8D01F810CFABQ33784759-266AB1DD-15BE-4839-866B-F05DE0AE1303Q33785351-7AB9BE21-69FF-4E13-ABB9-A2A9F2F30C8DQ33787084-A6AC0F03-0FDE-4826-AB08-0C55FC05C750Q33800960-E82D3A6A-D2D5-4C9F-9662-484387E0067CQ33803814-672C18DE-0E28-412E-9905-97ACE698F4FFQ33808429-3171F9C9-52BF-412D-BE81-740C3F0494E1Q33809347-0903C79A-20C4-4A59-8C05-B445BB278BCAQ33813648-E01B7C2D-A5C0-477D-9E3C-C14E1DC2FF43Q33814996-C5855BB2-7BAF-480C-9E26-8CFBC984E1FCQ33815436-ECA31239-FCFE-4423-B952-D6F2632FAE06Q33816490-E0F718F9-794C-41D1-92A0-74E8BC4523A7Q33820522-BE798495-93E1-4853-8CD0-CFCB0D15C0E9Q33827168-166239AA-5394-40E2-8976-7304BA55D9D1Q33843462-11C7C23E-BDD4-4571-BC25-7C16425574C6Q33874447-35A6F468-A1A8-4BD8-9B2B-77E11ADCB200Q33952099-EA7F3CEC-BC52-43D8-912E-D09C26F95E96Q34068037-2FE88EB7-B030-425B-B408-3CB5B0B4B301Q34123957-36795E2C-9303-4B0D-93F9-C741BF7450A4Q34288376-E5E184B4-B357-4A20-8519-31111C2EEAFDQ34302330-E8D0037E-36C1-462A-A111-D22EB20E6759
P2860
Functional chimeras of the Rous sarcoma virus and human immunodeficiency virus gag proteins
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Functional chimeras of the Rou ...... odeficiency virus gag proteins
@ast
Functional chimeras of the Rou ...... odeficiency virus gag proteins
@en
type
label
Functional chimeras of the Rou ...... odeficiency virus gag proteins
@ast
Functional chimeras of the Rou ...... odeficiency virus gag proteins
@en
prefLabel
Functional chimeras of the Rou ...... odeficiency virus gag proteins
@ast
Functional chimeras of the Rou ...... odeficiency virus gag proteins
@en
P2093
P2860
P1433
P1476
Functional chimeras of the Rou ...... odeficiency virus gag proteins
@en
P2093
P2860
P304
P407
P577
1993-11-01T00:00:00Z